Jeremiah Brown

Jeremiah Brown

Auto-generated profile, based on publicly available information

Jeremiah Brown

Fralin Biomedical Research Institute at VTC Addiction Recovery Research Center Roanoke VA USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2021 in Experimental and Clinical Psychopharmacology
Verified
Journal Article
Closed access
LALiqa N. Athamneh
Liqa N. Athamneh
JBJeremiah Brown
Jeremiah Brown
JSJeffrey S. Stein
Jeffrey S. Stein
KGKirstin M. Gatchalian
Kirstin M. Gatchalian
SLStephen M. LaConte
Stephen M. LaConte
WBWarren K. Bickel
Warren K. Bickel
Reinforcer Pathology theory proposes that expanding the temporal window of reinforcement (i.e., reducing delay discounting) using episodic future thinking (EFT) would decrease alcohol consumption. However, evidence of effectiveness in real-world settings is lacking. Using a randomized proof-of-concept field trial, the current study examined the effect of expanding the temporal window of reinforcement, using remotely delivered EFT, on decreasing real-world alcohol consumption among individuals with alcohol use disorder (AUD). Fifty-two individuals (9 females) aged 18–65 years who met the DSM-5 criteria for moderate or severe AUD and aimed to drink in moderation or abstain from drinking completed the study and were included in analysis. EFT significantly (p = .031) reduced alcohol consumption (mean change of consumption pre-post intervention = −2.18 drinks/day) compared to control episodic recent thinking (ERT; mean change of −0.52 drinks/day). Changes in discounting rates pre-post intervention significantly predicted changes in alcohol consumption (coef. = .424, 95% CI: .043-.813, p = .030) even after controlling for age, gender, race, income, education, marital status, and family history of addiction. Overall satisfaction across groups was rated as 3.92 on a 1 to 5-point scale, suggesting that the current remote approach is feasible and acceptable. The current findings were congruent with the theory, Reinforcer Pathology, that EFT expands the temporal window and decreases alcohol consumption, and the remote approach was considered feasible and acceptable. We believe the present study contributes new knowledge with tangible benefits for scientifically understanding and better defining novel interventions that may be clinically deployed to improve treatment outcomes.

18 April 2024 in Addictive Behaviors Reports
Verified
Journal Article
Open access
JBJeremiah M. Brown
Jeremiah M. Brown
MSMichael Sofis
Michael Sofis
SZSara Zimmer
Sara Zimmer
BKBrent Kaplan
Brent Kaplan
Excessive discounting of future rewards [delay discounting (DD)] may be a transdiagnostic process and treatment target underlying behavioral health outcomes, including trauma, depression, anxiety, and problematic substance use. However, multiple health behaviors and barriers are also related to these outcomes, including social media usage, adverse childhood experiences (ACEs), sleep quality, healthcare access, housing status, and exercise. To extend research examining DD as transdiagnostic process, we recruited a large, heterogenous sample to examine the association between DD, problematic substance use, and mental health outcomes while controlling for certain health behaviors and health barriers. In a cross-sectional online survey of 3992 US residents, we administered validated measures of PTSD, depression, anxiety, and problematic alcohol, stimulant, and opioid use. Using linear or ordinal logistic models, scores for each outcome were regressed onto DD while controlling for demographics, health behaviors, and health barriers. Including only DD and demographics, DD was associated with each outcome at low effect sizes (ƒ2 = .013, OR range = 1.08–1.16). Except for opioid ASSIST scores, these relationships held when controlling for social media usage, sleep, housing status, healthcare access, ACEs, physical exercise, and demographic variables (ƒ2 = .002, OR range = 1.03–1.12), increasing confidence that DD concurrently and directly relates to four of these five clinical outcomes. These findings support the conceptualization of DD as a transdiagnostic process underlying certain psychopathologies and suggest targeting DD in co-occurring substance use disorder and/or mental health treatments may result in clinically significant outcomes.

6 July 2021 in The Psychological Record
Verified
Journal Article
Closed access
PDF file
JBJeremiah Brown
Jeremiah Brown
WWWendy Donlin Washington
Wendy Donlin Washington
JSJeffrey S. Stein
Jeffrey S. Stein
BKBrent Kaplan
Brent Kaplan

3 August 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JBJeremiah M. Brown
Jeremiah M. Brown
WBWarren K. Bickel
Warren K. Bickel
LELeonard H. Epstein
Leonard H. Epstein
JSJeffrey S. Stein
Jeffrey S. Stein
Episodic Future Thinking (EFT) reduces delay discounting and may have the potential as a clinical tool to increase the likelihood of health-promoting behaviors. However, evaluations of EFT in clinical settings require control conditions that match the effort and frequency of cue generation, as well as participants’ expectations of improvement. The Health Information Thinking (HIT) control addresses these issues, but how this control affects delay discounting in individuals with diabetes and obesity when utilizing diabetes-management specific health-information vignettes is unknown. Moreover, little research has explored whether EFT reduces delay discounting in individuals with type 2 diabetes. To this end, we examined the impact of EFT, HIT, and a secondary no-cue control condition (NCC; assessments as usual) on delay discounting in 434 adults with self-reported type 2 diabetes and obesity recruited using Amazon Mechanical Turk. After completing an initial screening questionnaire, eligible participants reported demographics, then were randomized to EFT, HIT, or NCC conditions. Following the generation of seven EFT or HIT cues, participants assigned to EFT or HIT conditions completed a delay discounting task while imagining EFT or HIT cues; no-cue participants completed the task without cues. EFT participants demonstrated significantly lower delay discounting levels than HIT or NCC participants; no differences in delay discounting between HIT and NCC participants were observed. These results suggest that engaging in EFT, but not diabetes-specific HIT, results in lower delay discounting in adults with type 2 diabetes and obesity. This provides further evidence for the appropriateness of the HIT control for clinical trials examining the effect of EFT on delay discounting in adults with self-reported type 2 diabetes.

1 June 2022 in Experimental and Clinical Psychopharmacology
Verified
Journal Article
Closed access
Roberta Freitas LemosRoberta Freitas Lemos
Roberta Freitas Lemos
JSJeffrey S. Stein
Jeffrey S. Stein
DPDerek A. Pope
Derek A. Pope
JBJeremiah Brown
Jeremiah Brown
MFMarc Feinstein
Marc Feinstein
WBWarren K. Bickel
Warren K. Bickel
E-cigarette use is prohibited in most smoke-free environments. The effect of this policy on tobacco consumption could be examined using the Experimental Tobacco Marketplace (ETM). The ETM allows observation of policy on smokers' purchasing behavior under conditions that simulate "real-world" circumstances. A within-subject design was used to evaluate the effect of workplace policy (Vaping Allowed vs. Not Allowed) and nicotine concentration (24 mg/mL vs. 0 mg/mL) on tobacco product consumption. Participants (n = 31) completed one sampling and two ETM/workplace sessions per week for 2 weeks. During the sampling session, participants were given an e-cigarette with a 2-day supply of a commercially available e-liquid of their preferred flavor. Before purchasing, participants were informed whether e-cigarette use was permitted. During the four ETM sessions, participants purchased for the following 24 hr, including the 4-hr work shift that started immediately after buying products in the ETM. The workplace session consisted of data entry tasks in a mock office environment. Participants could use any purchased tobacco products during two 15-min breaks. Condition order was counterbalanced. The results show that permitting E-cigarette use in the workplace increased e-liquid purchase on average, but nicotine concentration had no effect on e-liquid demand. Cigarette demand was unaltered across conditions. The present study suggests that allowing e-cigarette use in the workplace would increase demand for e-liquid regardless of nicotine strength. However, it would not change conventional cigarette demand. (PsycInfo Database Record (c) 2022 APA, all rights reserved).

7 October 2025 in Journal of the Experimental Analysis of Behavior
Verified
Journal Article
Open access
JSJeffrey S. Stein
Jeffrey S. Stein
ATAllison N. Tegge
Allison N. Tegge
JBJeremiah M. Brown
Jeremiah M. Brown
KCKelsey M. Curran
Kelsey M. Curran
WBWarren K. Bickel
Warren K. Bickel
Using the Experimental Tobacco Marketplace, we examined the effects of e‐liquid freebase nicotine strength (3–24 mg/mL) and e‐liquid price (US$0.25–$1.00/mL) on behavioral economic substitution for cigarettes in dual cigarette/e‐cigarette ( n = 41) and exclusive cigarette ( n = 40) users. Subjective effects of nicotine strength were also examined. All nicotine strengths served as a substitute for combustible cigarettes, with greater substitution observed in dual users. When analyzing e‐liquid volume purchased (mL), nicotine strength did not influence substitution; however, when analyzing e‐liquid nicotine purchased (mg), degree of substitution increased as a function of nicotine strength. Additionally, higher nicotine strengths reduced the volume and probability of e‐liquid purchasing, increased cigarette demand, and produced less favorable subjective effects than lower strengths. Increasing e‐liquid price reduced e‐liquid purchasing and did not influence substitution. We conclude that nicotine strength does not robustly affect the degree to which e‐liquid substitutes for cigarettes, as no effect was observed in analysis of the unit of purchase most relevant to real‐world sales (volume). Instead, high‐strength nicotine potentially reduces the appeal and probability of purchasing e‐liquid. Future work should examine these effects in nicotine salt‐based e‐liquids compared with freebase nicotine (used here) and in choice contexts with concurrent access to different nicotine strengths.